Viralsol warning letter
This article was originally published in The Tan Sheet
Executive SummaryDietary supplement Viralsol is an illegally marketed drug because it is intended to cure, mitigate, treat or prevent a disease, FDA says in a recent warning letter to the Yorba Linda, Calif.-based firm. FDA takes issue with claims that the product will "halt HIV infection in human cells," "suppress recurrence" of Hepatitis A, B and C, and mitigate herpes outbreaks and West Nile virus. The company does not list Viralsol's ingredients on the website where the supplement can be purchased, but states the product has "been shown to exhibit potent antiviral properties" against influenza and hemorrhagic fever viruses...
You may also be interested in...
Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.
Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.